Jane Grogan


Dr. Grogan is the Chief Scientific Officer of Graphite Bio, a next-generation gene editing company focused on developing therapies to cure serious, life-threatening genetic diseases.

Prior to this, she was Chief Scientific Officer at ArsenalBio, and Head of Adaptive Tumor Immunity and Principal Scientist in Cancer Immunology discovery research at Genentech for over 15 years.

Dr. Grogan received a Ph.D. in Immunology at Leiden University in The Netherlands. She completed post-doctoral training at the German Rheumatism Research Centre Berlin as an Alexander von Humboldt Fellow and at the University of California, San Francisco as a Howard Hughes Fellow.